Table 2 Baseline characteristics by treatment arm
From: Supporting medication adherence for adults with cystic fibrosis: a randomised feasibility study
| Â | Intervention | Control | Overall |
|---|---|---|---|
Age | |||
 n | 33 | 31 | 64 |
 Mean (SD) | 31.6 (13.3) | 27.8 (8.9) | 29.7 (11.5) |
 Median (IQR) | 28 (21,37) | 26 (20,34) | 27 (21,36) |
Sex | |||
 Male | 18 (55%) | 18 (58%) | 36 (56%) |
 Female | 15 (45%) | 13 (42%) | 28 (44%) |
Socioeconomic Status | |||
 Most deprived | 6 (18%) | 1 (3%) | 7 (11%) |
 High deprivation | 4 (12%) | 7 (23%) | 11 (17%) |
 Average | 8 (24%) | 8 (26%) | 16 (25%) |
 Low deprivation | 6 (18%) | 9 (29%) | 15 (23%) |
 Least deprived | 9 (27%) | 6 (19%) | 15 (23%) |
FEV1% Predicted | |||
 n | 33 | 31 | 64 |
 Mean (SD) | 53.4 (19.4) | 61.4 (22.7) | 57.3 (21.3) |
 Median (IQR) | 49.2 (39.4,61.9) | 53.4 (43,80) | 49.6 (41.9,76.7) |